James Gilleen

6PUBLICATIONS
65CO-AUTHORS
Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Memory and attentionChild and adolescent developmentHealth psychologyCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 18, 2026
Multiscale characterization of cortical signatures in positive and negative schizotypy: a worldwide ENIGMA study.

|Mar 11, 2026
Enhancement of memory network activity in schizophrenia patients by phosphodiesterase-4 (PDE4) inhibitor, roflumilast: A pilot study.

Klaudia Stanoch, Donni Ann Staley, Peter Hawkins

|Oct 20, 2023
Childhood trauma moderates schizotypy-related brain morphology: analyses of 1182 healthy individuals from the ENIGMA schizotypy working group.

Yann Quidé, Oliver J Watkeys, Emiliana Tonini

|Apr 29, 2021
Impact of the COVID-19 pandemic on the mental health and well-being of UK healthcare workers.

James Gilleen, Aida Santaolalla, Lorena Valdearenas

|Aug 29, 2020
The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial.

James Gilleen, Judith Nottage, Farah Yakub

|Dec 12, 2018
An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.

James Gilleen, Yakub Farah, Cate Davison

Pageof 1

Frequent Collaborators

2 joint publications

Yann Quidé

2 joint publications

Lukasz Smigielski

2 joint publications

Elisabeth J Leehr

2 joint publications

Janik Goltermann